Diseases [C] » Infections [C01] » Virus Diseases » RNA Virus Infections » Mononegavirales Infections » Filoviridae Infections » Hemorrhagic Fever, Ebola
Diseases [C] » Infections [C01] » Virus Diseases » RNA Virus Infections » Hemorrhagic Fevers, Viral » Hemorrhagic Fever, Ebola
Description
A highly fatal, acute hemorrhagic fever caused by EBOLAVIRUS. MeSH
Hierarchy View
Approved Indicated Drugs (7)
Phase 3 Indicated Drugs (4)
Phase 2 Indicated Drugs (6)
Phase 1 Indicated Drugs (27)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (21)
Centers for Disease Control and Prevention (CDC)
Coalition for Epidemic Preparedness Innovations
Government of the Democratic Republic of the Congo
Institut National de la Santé Et de la Recherche Médicale, France
Organization Involved with Phase 2 Indications (34)
Beijing Institute of Biotechnology
Beijing Institute of Pharmacology and Toxicology
Bill and Melinda Gates Foundation
Canadian Immunization Research Network
Centers for Disease Control and Prevention, China
Organization Involved with Phase 1 Indications (32)
Organization Involved with Other Experimental Indications (1)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
